These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26034617)

  • 1. Impact of recall period on primary brain tumor patient's self-report of symptoms.
    Armstrong TS; Vera-Bolanos E; Acquaye A; Gilbert MR; Mendoza TR
    Neurooncol Pract; 2014 Jun; 1(2):55-63. PubMed ID: 26034617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module.
    Armstrong TS; Gning I; Mendoza TR; Vera-Bolanos E; Gilbert MR; Rhines LD; Weinberg JS; Sanchez-Williams G; Levin V; Burton AW; Cleeland C
    J Neurosurg Spine; 2010 Apr; 12(4):421-30. PubMed ID: 20367379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation study of the Japanese version of MD Anderson Symptom Inventory for Brain Tumor module.
    Tanaka S; Sato I; Takahashi M; Armstrong TS; Cleeland CS; Mendoza TR; Mukasa A; Takayanagi S; Narita Y; Kamibeppu K; Saito N
    Jpn J Clin Oncol; 2020 Jul; 50(7):787-793. PubMed ID: 32280995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does recall period have an effect on cancer patients' ratings of the severity of multiple symptoms?
    Shi Q; Trask PC; Wang XS; Mendoza TR; Apraku WA; Malekifar M; Cleeland CS
    J Pain Symptom Manage; 2010 Aug; 40(2):191-9. PubMed ID: 20579835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric validity and reliability of the Danish version of the MD Anderson Symptom Inventory Brain Tumor Module.
    Piil K; Whisenant M; Mendoza T; Armstrong T; Cleeland C; Nordentoft S; Williams LA; Jarden M
    Neurooncol Pract; 2021 Apr; 8(2):137-147. PubMed ID: 33898047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of the MDASI-BT in patients with brain metastases.
    Armstrong TS; Gning I; Mendoza TR; Weinberg JS; Gilbert MR; Tortorice ML; Cleeland CS
    J Pain Symptom Manage; 2009 Mar; 37(3):331-40. PubMed ID: 18676120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT).
    Armstrong TS; Mendoza T; Gning I; Coco C; Cohen MZ; Eriksen L; Hsu MA; Gilbert MR; Cleeland C
    J Neurooncol; 2006 Oct; 80(1):27-35. PubMed ID: 16598415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congruence of primary brain tumor patient and caregiver symptom report.
    Armstrong TS; Wefel JS; Gning I; Acquaye A; Vera-Bolanos E; Gilbert MR; Cleeland CS; Mendoza T
    Cancer; 2012 Oct; 118(20):5026-37. PubMed ID: 22415423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying symptom recurrences in primary brain tumor patients using the MDASI-BT and qualitative interviews.
    Acquaye AA; Payén SS; Vera E; Williams LA; Gilbert MR; Weathers SP; Armstrong TS
    J Patient Rep Outcomes; 2019 Aug; 3(1):58. PubMed ID: 31444579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cross-sectional Study on the Symptom Burden of Patients With Spinal Tumor: Validation of the Chinese Version of the M.D. Anderson Symptom Inventory-Spine Tumor Module.
    Xu N; Li Z; Wei F; Liu X; Jiang L; Meng N; Jiang P; Yu M; Wu F; Dang L; Zhou H; Li Y; Liu Z
    J Pain Symptom Manage; 2017 Mar; 53(3):605-613. PubMed ID: 28042067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN).
    Wang XS; Shi Q; Williams LA; Cleeland CS; Garcia-Gonzalez A; Chen TY; Shahid DR; Ramirez PT; Iniesta MD; Siverand AM; Meyer LA
    Gynecol Oncol; 2019 Mar; 152(3):492-500. PubMed ID: 30876494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory Gastrointestinal Cancer Module (MDASI-GI-C).
    Chen RW; Yang SL; Xu ZY; Peng M; Chen MN; Wang QS; Chang J; Hu JL
    J Pain Symptom Manage; 2019 Apr; 57(4):820-827. PubMed ID: 30684634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptoms.
    Armstrong TS; Vera-Bolanos E; Acquaye AA; Gilbert MR; Ladha H; Mendoza T
    Neuro Oncol; 2016 Feb; 18(2):252-60. PubMed ID: 26289592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncertainty, mood states, and symptom distress in patients with primary brain tumors: analysis of a conceptual model using structural equation modeling.
    Lin L; Chiang HH; Acquaye AA; Vera-Bolanos E; Gilbert MR; Armstrong TS
    Cancer; 2013 Aug; 119(15):2796-806. PubMed ID: 23661311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the MD Anderson Symptom Inventory-Head-and-Neck-Filipino (MDASI-HN-F): clinical utility of symptom screening among patients with head-and-neck cancer.
    Bacorro WR; Sy Ortin TT; Suarez CG; Mendoza TR; Que JC
    BMJ Support Palliat Care; 2017 Jun; 7(2):140-149. PubMed ID: 25941198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failure.
    Fadol A; Mendoza T; Gning I; Kernicki J; Symes L; Cleeland CS; Lenihan D
    J Card Fail; 2008 Aug; 14(6):497-507. PubMed ID: 18672198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between corticosteroids and symptoms in patients with primary brain tumors: utility of the Dexamethasone Symptom Questionnaire-Chronic.
    Armstrong TS; Ying Y; Wu J; Acquaye AA; Vera-Bolanos E; Gilbert MR; Brown PD; Vardy J; Chung C
    Neuro Oncol; 2015 Aug; 17(8):1114-20. PubMed ID: 25862766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory.
    Mendoza T; Sheshadri A; Altan M; Hess K; George G; Stephen B; Castillo L; Rodriguez E; Gong J; Peterson C; Rodon Ahnert J; Fu S; Piha-Paul SA; Pant S; Dumbrava E; Yap TA; Janku F; Tsimberidou AM; Subbiah V; Karp DD; Zarifa A; McQuinn LM; Cleeland C; Hong DS; Naing A
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33097611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian version of the M.D. Anderson Symptom Inventory--Head and Neck Module: linguistic validation.
    Greco A; Orlandi E; Mirabile A; Takanen S; Fallai C; Iacovelli NA; Rimedio A; Russi E; Sala M; Monzani D; Rosenthal DI; Gunn GB; Steca P; Licitra L; Bossi P
    Support Care Cancer; 2015 Dec; 23(12):3465-72. PubMed ID: 25791393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language.
    Sánchez D; Chala A; Alvarez A; Payan C; Mendoza T; Cleeland C; Sanabria A
    J Pain Symptom Manage; 2016 Jun; 51(6):1055-61. PubMed ID: 26899822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.